Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection

スポンサーリンク

概要

• 論文の詳細を見る
• 1996-09-30

著者

• ITOH Kyogo

  Departments of Immunology, Kurume University School of Medicine

• SATA Michio

  Second Department of Internal Medicine, Kurume University

• TANIKAWA Kyuichi

  Second Department of Medicine, Kurume University School of Medicine

• Itoh K

  Kurume Univ. School Of Medicine Fukuoka Jpn

• SUZUKI Hiroshi

  Second Department of Medicine, Kurume University School of Medicine

• Tanikawa Kyuichi

  Second Department Of Internal Medicine Kurume University School Of Medicine

• Itoh Kyogo

  Department Of Immunology

• NAGAO Yumiko

  Department of Oral Surgery, Kurume University School of Medicine

• KAMEYAMA Tadamitsu

  Department of Oral Surgery, Kurume University School of Medicine

• Nagao Yumiko

  Department Of Oral Surgery Kurume University School Of Medicine

• Sata Michio

  Second Dep. Of Internal Medicine Kurume Univ. School Of Medicine

• Kawaguchi Takumi

  Department Of Digestive Disease Information & Research Kurume University School Of Medicine

• Nagao Yumiko

  久留米大学 口腔外科

• Kameyama Tadamitsu

  Department Of Oral And Maxillofacial Surgey Kurume University School Of Medicine

• Saito Hiroshi

  Yamanashi University

• KAMEYAMA TADAMITSU

  Department of Dentistry and Oral Surgery, Kurume University School of Medicine

• NAGAO YUMIKO

  Department of Oral Surgery

• NAGAO Yumiko

  Department of Digestive Disease Information and Research, Kurume University School of Medicine

関連論文

• Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease
• Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
• Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
• Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
• A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
• Timing of interferon therapy and sources of infection in patients with acute hepatitis C
• Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
• A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
• A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
• Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
• Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia
• Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
• Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
• Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
• Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
• Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
• Endotoxin increases paracellular permeability of isolated rat hepatocyte couplets
• High prevalence of anticardiolipin antibodies in hepatitis C virus infection : lack of effects on thrombocytopenia and thrombotic complications
• Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
• Immunoregulatory cytokines and intestinal inflammation
• Intestinal microflora as a therapeutic target in inflammatory bowel disease
• Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
• Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
• Cytomegalovirus Pneumonitis Presenting Small Nodular Opacities
• Propranolol ameliorates thrombocytopenia in patients with cirrhosis
• Upright posture blunts postprandial splanchnic hyperemia in patients with cirrhosis and portal hypertension
• Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment
• Investigation of associating factors in exacerbation of liver damage after chemotherapy in patients with HBV-related HCC
• GB virus C (GBV-C)/hepatitis G virus (HGV) infection in a hepatitis C virus hyper-endemic area in Japan
• Cytotoxicity Induced by Erythrina variegata Serine Proteinase Inhibitors in Tumor Hematopoietic Stem Cell Lines
• Involvement of arterial blood supply in the proliferarion of hepatocellular carcinoma
• OVEREXPRESSION OF MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE (MT1-MMP), MATRIX METALLOPRATEINASE-2 (MMP-2) IS ASSOCIATED WITH TUMOR DEVELOPMENT IN HEPATOCELLULAR CARCINOMA (HCC).
• Two-year follow-up study after treatment with lamivudine for chronic hepatitis B : seven cases reported
• Development of a new method for detecting a mutation in the gene encoding hepatitis B virus reverse transcriptase active site (YMDD motif)
• Erythropoietic protoporphyria with fatal liver failure
• Intracellular traffic of asialoglycoproteins depends on vacuolar pH in polarized isolated rat hepatocyte couplets
• Antiphospholipid syndrome modifies the clinical features of systemic lupus erythematosus
• Personalized peptide vaccines : A new therapeutic modality for cancer
• Expression of Tumor-rejection Antigens in Gynecologic Cancers
• Expression of the SART-1 Antigens in Uterine Cancers
• Target molecules in specific immunotherapy against prostate cancer
• Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients
• Expression of MAGE-1 Gene by Esophageal Carcinomas
• Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Colon Cancer
• Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
• Changes in the Mononuclear Cell Subpopulations of Rat Cardiac Transplant Recipients Administered FK506 for the Treatment of Ongoing Rejection
• Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
• Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
• Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
• Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
• Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
• Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
• Identification of Cyclophilin B-derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes
• Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
• Spectroscopic Analysis of the Cytoagglutinating Activity of Abrin-b Isolated from Abrus precatorius Seeds against Leukemic Cells
• A GENE ENCODING SQUAMOUS CELL CARCINOMA ANTIGENS RECOGNIZED BY CYTOTOXIC T LYMPHOCYTE
• Genes Encoding Antigenic Peptides of Human Epithelial Cancers Recognized by Cytotoxic T Lymphocytes
• Detection of MAGE-4 Protein in Sera of Lung Cancer Patients
• Human Tumor Rejection Antigens MAGE1^1
• Cytokine Production by T Cells Infiltrating in the Eye of Uveitis Patients
• Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
• In Vitro Effects of Immunosuppressive Agents on Cytokine Production by HTLV-I-Infected T Cell Clones Derived from the Ocular Fluid of Patients with HTLV-I Uveitis
• Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanona antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
• In Vitro Study of Neutrophil Apoptosis in Liver Cirrhosis
• Selection and timing of liver transplantation in primary biliary cirrhosis
• Role of extravariceal collateral channels in the development of portal-hypertensive gastropathy before and after sclerotherapy
• High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
• Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes
• Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
• Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
• Dextromethorphan for neuropathic pain with Churg-Strauss syndrome
• Polyarteritis nodosa with mesenteric aneurysms demonstrated by angiography : report of a case and successful treatment of the patient with prednisolone and cyclophosphamide
• Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan
• Serological Study of Bartonella henselae in Cat Scratch Disease in Japan
• Long-term improvement of hepatic fibrosis in chronic hepatitis C treated with interferon-α
• Effects of OK-432 on matrix metalloproteinase-9 expression and activity in rat cultured Kupffer cells
• Functional liver imaging with asialoglycoprotein receptors and serum hyaluronate in a patient with amyloidosis
• Analysis of serum hepatitis A virus antibody response in different courses of hepatitis A virus infection
• A pilot study of natural interferon γ therapy for chronic hepatitis C
• A Case-Control Study on Male Hepatocellular Carcinoma Based on Hospital and Community Controls
• Sequence Variation of the Hypervariable Region in HCV Carriers with Normal ALT Levels:A Comparison with Symptomatic Carriers
• Usefulness of ED036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma
• High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection
• Natural disappearance of serum HCV RNA: prospective study in a hyperendemic area
• Ligation plus low-volume sclerotherapy for high-risk esophageal varices : Comparisons with ligation therapy or sclerotherapy alone
• Influence of extravariceal collateral channel pattern on recurrence of esophageal varices after sclerotherapy
• Association of HLA-DRB1 0803 and 1602 with the susceptibility to primary biliary cirrhosis
• Secretory IgA anti-HAV in bile of hepatitis A patients
• Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B
• Secretory IgA anti-HAV in saliva of hepatitis A patients
• Decreased regional cerebral blood flow during interferon therapy
• Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
• Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
• Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
• Second generation amplicor-HCV monitor assay : clinical features and predictors of the response to interferon
• Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients
• The Localization of HCV and the Expression of Fas Antigen in the Liver of HCV-related Chronic Liver Disease
• Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide
• Multiple primary neoplasms and hepatitis C virus infection in oral cancer patients
• Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection

もっと見る 閉じる

スポンサーリンク